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ABSTRACT
￿
We have shown that erythropoietin (epo), the primary regulator of erythrocyte formation,
diminished the binding to peritoneal exudate macrophages (PEM) of the principal macrophage
growth regulator, colony-stimulating factor (CSF-1). The effect of epo on 1251-CSF-1 binding was
dose-dependent; at a concentration of 1-2 U of epo/ml (10-1° M), CSF-1 binding was almost
completely suppressed. Erythropoietin did not compete with CSF-1 for occupancy of the latter's
receptors. The effect of epo on CSF-1 binding occurred at 37°C but not at 2°C, and during the
continuous exposure of PEM to epo at 37°C we found that CSF-1 binding reached a nadir at 1 h and
recovered to pre-exposure levels in 7 h .
Our novel results are consistent with the notion that specific receptors for epo exist on the cell
surface of PEM and that binding of epo sets in motion a series of cellular events resulting in the
internalization of CSF-1 receptors. Thus epo causes down regulation of CSF-1 receptors on PEM .
We have previously shown that epo causes suppression of CSF-induced granulocyte-macrophage
colony formation by mouse bone marrow cells. The results we present here provide a possible
mechanism for these results .
Erythropoietin (epo)' and colony-stimulating factor (CSF) are
regulators of hemopoietic cell proliferation and differentia-
tion. Epo is the primary, if not sole, effector of erythrocyte
formation in vivo and in vitro, and CSF-1, at least in vitro,
causes macrophage proliferation and differentiation (1-4).
One of us (G. Van Zant) has found that the two regulators
compete for expression of their respective differentiation ac-
tivities when added to bone marrow cells in vitro (5, 6). We
therefore have determined whether or not epo affects the
initial step in macrophage regulation by CSF-1, namely, bind-
ing ofCSF-1 to specific cell surface receptors thatare restricted
to mononuclear phagocytesand their precursors and to estab-
lished macrophage cell lines only (7, 8). It is believed that
CSF-1 receptors mediate both proliferation and other biolog-
ical functions of target cells(4, 7).
Other growth regulators have been shown to modulate the
number ofreceptors with specificity for another effector bind-
ing to the same cell. For example, platelet-derived growth
'Abbreviations usedin thispaper:
￿
CSF-1, colony-stimulating factor-
' ; EGF, epidermal growth factor; epo, erythropoietin; LIPS, lipopoly-
saccharide; PDGF, platelet-derived growth factor; PEM, peritoneal
exudate macrophages.
THE JOURNAL OF CELL BIOLOGY " VOLUME 97 DECEMBER 1983 1945-1949
®The Rockefeller University Press - 0021-9525/83/12/1945/05 $1.00
factor (PDGF) decreases the number of specific receptors for
epidermal growth factor (EGF) on mouse 3T3 cells (9, 10)
and EGF has been shown to reduce the number of receptors
for human choriogonadotropin on Leydig tumor cells (11).
We report here that epo causes a reduction in the number
of CSF-1 receptors on macrophages in a pattern dependent
on dose, temperature, and time.
MATERIALS AND METHODS
Mice:
￿
We used male C3H/HeJ mice 8-12 wk old from our specific
pathogen-free animal facilities for these studies.
Macrophage Harvest:
￿
We harvested peritoneal exudate cells (PEM)
asdescribed byChen et al. (12) by peritoneal lavagewith ice-coldalpha medium
3 d after asingle intraperitoneal injection of 1.5 ml of thioglycollate medium
(Difco Laboratories, Detroit, MI). Cells were washed once with alpha medium
containing 10% fetal calfserum (alpha-10) (Hyclone, Logan, UT)by centrifu-
gation (500 g, 10 min) in the cold. Thelot ofserum selected for these studies
contained <1 ng of endotoxin/ml. Adherent macrophages were selected by
plating exudate cells in 1 ml ofalpha-10 in 35-mm polystyrene tissue culture
dishes for 15 min at 37°C. We removed nonadherent cells by washing once
with PBSat pH 7.2. Adherent cells consisting of more than 95% mononuclear
phagocytes were cultured in alpha-10 at 37°C for 20 h in a humidified atmos-
phere of 10%C02 in air before they were used for study.
/774 Cells:
￿
This macrophage cell line was originally isolated by Ralph
1945(l3) and was obtained by us from the Cancer Cell and Virus Center at this
university.
Determination of 125/-CSF-1 Binding:
￿
We washed macrophages
twice with cold PBS, and the cells were subsequently bathed in 0.9 ml of cold
alpha-10 buffered to pH 7.2 with 20 mM morpholinopropane sulfonic acid
(Sigma Chemical Co., St. Louis, MO) instead ofthe usual bicarbonate. Labeled
CSF-I was added in a volume of 100 jA1, and the cells were incubated at 2°C
for 16 h. We removed unbound 12'I-CSF-1 by washing the cells three times
with cold PBS. We then lysed the cells with 0.75 ml of50 mM Tris-HCI, 0.5%
SDS at pH 7.4 (7, 8) and removed the lysate from the dish for counting in an
automatic gamma counter. Nonspecific binding, determined as the amount of
"'I-CSF-I bound in the presence of a 200-fold excess of unlabeled CSF-l, was
always <2% of the total binding, and we subtracted this value from the total
counts to obtain specific binding.
Purification and Iodination of CSF-1 :
￿
Murine L-cell CSF-I was
purified according to the methods described previously (3, 8). To determine
the purity, we used SDS PAGE at 9 and 12.5% acrylamide concentration. Co-
migration of biological activity and labeled protein was used as the index of
purity (3, 8). BiologicalactivityofCSF-I was determined by the standardization
method described by van den Engh (14) and the material we used had aspecific
activity of 5 x 10' U/mg of protein. Purified CSF-1 was iodinated by the
method described by Stanley and Guilbert (15) with slight modification. We
prepared high specific activity 12'I-CSF-1 (150-300,uCi/Rg protein) by iodinat-
ing l kg ofCSF-I with 2 mCi ofcarrier-free Nal"' (Industrial Nuclear Co., St.
Louis, MO). "'I-CSF-I prepared in this manner retained its biological activity
and also reacted with either rabbit or rat anti-CSF-1 antiserum (l5, 16). We
used 12'1-CSF-I within 4 wks of iodination since itsbiological activity decreases
with time (tii2 = ^"6 wks).
Erythropoietin (epo):
￿
We used partially purified human urinary epo
(CAT-1) for these studies. It was obtained from the Division ofBlood Diseases
and Resources of The National Heart, Lung, and Blood Institute and had a
specific activity of 1,140 U/mg of protein; pure human urinary epo has a
specific activity of 70,400 U/mg ofprotein (17). The CAT-1 epo was prepared
by Dr. Eugene Goldwasser of the University of Chicago and was essentially
freed ofany contaminating endotoxin by an ultracentrifugation step. Less than
20 pg ofendotoxin per unit of epo was measured by Limulus lysate test of this
preparation. In addition this preparation is virtually free of CSF activity,
including CSF-1, and is free of burst-promoting activity.
Epo Bioassay:
￿
Epo in the medium over macrophages was assayed by
measuring induced "Fe incorporation into hematin synthesized by mouse
marrow cells, as we have previously described (18). Bone marrow cells (5 x
l0'/ml) were cultured for 48 h in the wells ofCostar tissue culture trays (model
3524, Costar, Cambridge, MA); six replicate cultures were run for each exper-
imental point. The medium consisted ofa-minimal essential medium contain-
ing 0.8% methyl cellulose (4,000 cps, Dow Chemical Co., Midland, MI), 20%
fetal calfserum, I % BSA (Sigma ChemicalCo.) and 10-° M 0-mercaptoethanol.
At 24 h we added radioiron-labeled rat transferrin (0.2 uCi in 20 jut) to each
well and 24 h laterwe harvested cellsandextracted hematin into cyclohexanone.
Results are expressed as mean "Fe cpm in hematin ± 1 SD.
RESULTS
Table I shows that preincubation of PEM with epo caused a
dose-dependent inhibition of subsequent CSF-1 binding. In
these two representative experiments, a 1-h exposure of cells
at 37°C to 0.12 U of epo caused a 25% inhibition of subse-
quent CSF-1 binding. Higher epo concentrations caused pro-
gressive suppression and, at a concentration of 2 U of epo/
ml, suppression was virtually complete. In three other exper-
iments of this type we found that inhibition was always
detectable at a concentration of 0.12 U/ml of epo and that
1-2 U/ml completely prevented CSF-1 binding. It appeared
that a concentration of -0.1 U of epo/ml was a threshold
level since lowerconcentrations did not affect CSF-i binding
and higher concentrations reproducibly diminished binding.
We used partially purified human urinary epo for these
experiments; in other experiments not reported here we found
a qualitatively similar effect using a crude epo preparation
from an entirely different source in another species (anemic
sheep plasma). The sheep epo (4 U/mg ofprotein; Connaught,
Swiftwater, PA) was about one-fourth as effective per unit as
the human epo in causing inhibition of CSF-1 binding but
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was identical in potency to the human epo in stimulating
hemoglobin synthesis in mouse marrow cells.
Fig. 1 shows the results ofan experimentin which we added
graded concentrations of either epo or unlabeled CSF-1 to
PEM at the same time as we added "'I-CSF-1 . The PEM
were kept at 2°C during the incubation and after 16 h we
determined the 12'I-CSF-1 bound. In contrast with the dra-
maticinhibition caused by unlabeled CSF-1, epo did not have
a significant effect on the binding ofCSF-1 ; only the 2 U/ml
epo concentration caused any inhibition in CSF-1 binding,
and that amounted to only 11 %. These results show that epo
caused a decline in the number of available CSF-1 receptors
TABLE I
Effect of Epo Concentration on Subsequent Binding of CSF-I to
Macrophages
Adherent PEM (1 x 106/ml in Experiment 1 ; 4 x 105/ml in Experiment 2) were
incubated with the appropriate concentration of epo for 1 h at 37°C. The
cells were subsequently washed twice with fresh medium and "'I-CSF-1 was
added (100,000 cpm in Experiment 1 ; 50,000 cpm in Experiment 2). The cells
were then incubated for 16 h at 2°C and 1251-CSF-I (cpm) binding was
determined. Cellular binding of CSF-1 in duplicate 35-mm dishes is reported
in Experiment 1, and single dishes were used for each point in Experiment
2.
1
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FIGURE 1
￿
Effects on 1151-CSF-1 binding of simultaneously incubat-
ing macrophages at 2°C with either epo (closed circles) or CSF-1
(open circles). Adherent exudate macrophages, prepared as de-
scribed in Materials and Methods, were plated in duplicate 35-mm
polystyrene dishes (1 x 106 cells/dish) and exposed to several
concentrations of epo or CSF-1 at 2°C along with 1151-CSF-1
(100,000 cpm). Binding was determined after overnight incubation
(16 h); the data are reported as the means of specific cellular binding
(cpm) in the duplicate dishes and they have been corrected for
nonspecific binding.
Epo
Experiment
125 1-CSF-1
bound
1
% of
control
Experiment 2
1151-CSF-1 % of
bound control
U/ml cpm cpm
0 42,290 ± 1,010 - 6,830 -
0.06 - - 6,370 93
0.12 32,570 ± 3,030 77 4,890 72
0.25 9,940 ± 2,570 24 1,230 18
0.5 2,660 ± 65 6 410 6
1 .0 760 ± 100 2 250 4
2.0 190±2 0.4 - -(in Table I) through cellular mechanisms operable at 37°C,
but not at 2°C, and, moreover, that epo does not compete for
CSF-1 receptors.
Note that concentrations of epo and CSF-1 of 1 U/ml are
equivalent to molar concentrations of 4 x 10-'° M and 3 x
10-" M, respectively. The scales of the abscissas in Fig. 1
(and in Fig. 2, a and b) correspond to essentially equimolar
concentrations of the two growth regulators, and the two
curves can therefore be directly compared on a molar basis
since one epo unit equals 1,000 CSF-1 units.
Cells of the macrophage line J774 have previously been
shown to possess CSF-1 receptors (7, 19, and Chen and Hsu,
unpublished observation), and, as is true with PEM, prior or
simultaneous exposure of these cells to unlabeled CSF-1 di-
minishes binding ofthe labeled derivative. We therefore asked
whether or not epo had similar effects on J774 cellsand PEM.
We found that whereas CSF-1 inhibited its subsequent bind-
ing to both cell types, epo suppressed CSF-1 binding to only
the PEM (Fig. 2). This result demonstrates that epo inhibits
CSF-1 binding by a cell-specific mechanism(s) rather than by
having nonspecific, perhaps toxic, effects on macrophages. It
is readily apparent in Fig. 2 that the dose-dependent inhibition
caused by epo and CSF-I follows different patterns. In the
region of 50% inhibition on the two curves, the rate ofdecline
FIGURE 2
￿
The effects of epo and CSF-1 on 1251-CSF-1 binding to
J774 cells (open circles) and to PEM (closed circles). 1251-CSF-1
binding to macrophages (1 x 106/ml) or J774 cells (5 x 105/ml) was
measured as described in Materials and Methods after the cells
were first exposed for 1 h at 37°C to either epo (a) or CSF-1 (b).
The results are expressed as means of duplicate dishes at each
point. 50,000 cpm of 1251-CSF-1 was added to each dish, and the
control binding to macrophages and )774 cells was 24,700 and
27,908 cpm, respectively, in a; in b, it was 30,750 and 26,580 cpm,
respectively. Nonspecific binding to dishes containing 200-fold
excess of unlabeled CSF-1 averaged 2% in these experiments and
was subtracted from the experimental results to give specific cellular
binding.
with increasing epo concentrations is steeper than with in-
creasing CSF-1 concentrations and, as we mentioned before,
inhibition occurred only at epo levels above a threshold
concentration. Inhibition caused by CSF-I appeared to be
strictly dose-dependent and did not have a threshold since the
curve extrapolated through the 100% value.
We next studied 1251-CSF-1 binding to macrophages after
first exposing them (at 37°C) to 1 U/ml of epo for times
ranging from 30 min to 7 h. These results in Table II show,
first, a rapid eclipse in CSF-1 binding that reached a nadir of
- 1 % of control at 1 h and, secondly, a recovery in binding
commencing at 2 h that reached 87% of control levels by 7
h.
It should be stressed that the recovery of CSF-1 binding,
presumably through the reappearance of CSF-I receptors,
occurred while epo was still present in the incubation me-
dium. To verify that epo was not degraded during incubation,
we assayed the incubation medium aftervarious periods and,
as shown in Table III, we found no loss of epo after as much
TABLE II
Time-Course of Inhibition of CSF-I Binding Caused by Epo
Two sets of 35-mm dishes containing 1 x 106 PEM were set up: one set with
i U/ml of human urinary epo and the other set without epo. The plates were
cultured at 37°C and at selected times the media were collected for epo
assay (Table III), the cells were washed twice, and 1251-CSF-1 binding was
determined as described in Materials and Methods. 100,000 cpm of 1251-CSF-
1 was added to each dish.
TABLE III
Epo Bioassay of Macrophage Culture Medium
PEM culture medium either with or without 1 U/ml of added epo was
assayed after 1 or 7 h of incubation at 37°C. A volume of 20 yI of the
medium was added per milliliter to the suspension of bone marrow cells
in the assay. If there was no loss of epo during incubation, 20 )AI should
have contained 20 mU of epo, and we therefore compared the culture
medium with a 20 mU/ml concentration of epo added to the cells in the
assay. Epo-induced "Fe incorporation into hematin extracted from the
marrow cells was determined as described in Materials and Methods.
* Not significantly different (P> 0.05) than the response to 20 mU/mlof epo.
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Incubation
period
h
Epo
1 U/ml
1251-CSF-1
bound
cpm
Effect of epo
as % of con-
trol binding
0.5 - 46,470 -
+ 5,230 11
1 - 43,310 -
+ 600 1
2 - 44,830 -
+ 14,850 33
3 - 47,590 -
+ 31,120 65
5 - 44,640 -
+ 30,380 68
7 - 40,990 -
+ 35,810 87
Group Addition "Fe in hematin 0
cpm
1 None 12 ± 2 -
2 20 mU/ml of epo 183 ± 22 171
3 7 h macrophage medium, 14 ± 5 2
without epo
4 1 h macrophage medium, 161 ± 18 149*
with epo
5 7 h macrophage medium, 194 ± 14 182*
with epoas 7 h of incubation with the macrophages, a time at which
CSF-1 binding had recovered to near control levels (Table II) .
DISCUSSION
This is the first direct demonstration that one hemopoietic
growth regulator can affect the interaction of a second regu-
lator with its target cells . Our results clearly show that epo
inhibits CSF-1 binding to mouse peritoneal exudate macro-
phages . Inhibition was dose-dependent above a concentration
of 0 .1 U/ml of epo, and, at a concentration of 1-2 U/ml,
inhibition was complete. Human urinary epo has a molecular
weight of- 34,000 and purified material has a specific activity
of 70,400 U/mg of protein (17) . We therefore found that epo
suppressed CSF-1 binding at 10-"-10- '° M, i.e ., in the con-
centration range of physiologic regulators.
Secondly, we found that inhibition was temperature-de-
pendent ; incubation of macrophages with epo at 37°C, but
not at 2°C, caused a diminution in subsequent CSF-1 binding .
We (Fig . 1) as well as others (7) have shown that simultaneous
addition of epo and ' 211-CSF-1 to PEM in the cold does not
affect binding of the latter . These data taken together show
that epo does not inhibit CSF-1 binding by competing for the
latter'sreceptors . In contrast, our data are consistent with the
notion that epo caused down regulation of CSF-1 receptors
by binding to macrophages, perhaps via specific receptors for
epo, and subsequently causing a disappearance of CSF-1
receptors from the cell surface . Cells of the macrophage line
J774, like PEM, possess CSF-1 receptors but, in contrast with
what we found with PEM, epo did not causedown regulation
of CSF-1 receptors on J774 cells . On the basis of our working
hypothesiswe would conclude that J774 cells lack epo recep-
tors . Therefore, in the absence of specific epo binding, CSF-1
receptor down regulation does not occur on J774 cells as a
consequence of epo exposure . In support of this view that
J774 cells lack epo receptors, we find no change in J774 cell
proliferation in the presence of epo (unpublished observa-
tions). Since at present there is no epo tracer, either radiola-
beled or fluorescent, that retains biological activity, it is not
possible to identify epo receptors on macrophages or, for that
matter, on erythroid cells . Until a biologically active epo
derivative is available, the identity of cells with receptors will
remain speculative. From a teleological viewpoint, it is diffi-
cult to understand the occurrence of putative epo receptors
on PEM since epo plays no known role in macrophage growth
and function .
An alternative explanation for our results, namely that epo
caused a change in CSF-1 receptor affinity for its ligand,
cannot be ruled out in the present study . However, 12-0-
tetradecanoyl-phorbol-13-acetate, a tumor-promoting phor-
bol ester, and bacterial lipopolysaccharide (LPS), the only
other known inhibitors of CSF-1 binding to PEM, cause a
decline in the number of CSF-1 receptors on the PEM cell
surface rather than altering CSF-1 receptor binding affinity
(12, 27).
Internalization of ligand-receptor complexes is a frequently
reported consequence ofthe binding ofpolypeptide hormones
to cells (20-23), and recently this response has been charac-
terized by two helpful descriptive terms (11) . The term ho-
mologous down regulation has been used to describe the loss
of receptors, caused by a prior exposure of cells to the specific
ligand of the receptor in question. CSF-1 down regulates its
receptors in this way (24) as do other hormones and growth
factors (9-11, 25, 26) . The term heterologous down regulation
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has been used to describe the disappearance from the cell
surface of specific receptors for one ligand as a consequence
of the binding of another ligand to its unique receptors on
the same cell . We believe that the results reported in this
paper are an example of heterologous down regulation.
Other examples of heterologous down regulation include
(a) the loss ofEGF receptors on mouse 3T3 cells or human
fibroblasts caused by PDGF (9, 10) and (b) the loss of recep-
tors for human choriogonadotropin on mouse Leydig tumor
cells caused bymouseEGF (11) . Bowen-Pope et al . (10) found
that the PDGF-induced loss of EGF receptors on 3T3 cells
occurred at either 4° or 37°C . This is in contrast with our
results showing that epo caused a loss in CSF-1 receptors only
at 37°C and suggests that the mechanisms involved may be
different.
Our results in Table II suggest that after the initial eclipse
of CSF-1 receptors at 1 h, receptors reappeared in a time-
dependent manner even in the continuous presence of epo . It
is significant that the rate of reappearance ofCSF-1 receptors
after their initial exposure to epo is approximately the same
as the rate of their reappearance after they were removed by
trypsinization or the rate of appearance of unoccupied recep-
tors after they were first saturated with unlabeled CSF-1 (24) .
In each ofthe above cases, full 12'1-CSF-1 binding was attained
in 6-8 h . These results are similar to those ofWrann et al . (9)
in which they found that EGF receptors reappeared on 3T3
cells after their loss was triggered by incubation with PDGF .
These workers found that EGF receptors reappeared despite
the continued presence ofPDGF, and the rate ofreappearance
was similar to what we found for CSF-1 receptors .
One of us (B . D.-M . Chen) has previously reported that
tumor-promoting phorbol esters (27) and bacterial LPS (12)
cause down regulation of CSF-1 receptors on PEM . Several
points rule out the possibility that LPS, contamination of our
epo preparations accounts for the effects on CSF-1 binding
that we see . First, we used C3H/HeJ mice, a strain resistant
to the effects of LPS . Chen et al . (12) found that under
conditions identical to those used in the present studies, as
much as 100 ng/ml of LPS caused no diminution of CSF-1
binding whereas in the LPS-susceptible strain C3H/Anf, this
concentration ofLPS reduced binding to macrophages >95% .
Secondly, the human urinary epo preparation used in most
of our experiments, distributed by The National Institutes of
Health, contains <20 pg ofLPS per epo unit according to the
Limulus lysate test . Lastly, we have found that polymyxin B
does not affect the inhibition of CSF-1 binding caused by our
epo preparation (data not shown). Chen et al. (12) have shown
that polymyxin B completely abrogates the effect of LPS on
CSF-1 binding to macrophages ofC3H/Anfmice .
We have tested a number of other growth regulators for
their ability to modulate CSF-1 binding to macrophages
(Chen, unpublished data) . Pure PDGF (a gift of Jung San
Huang and Thomas Deuel, Jewish Hospital and Washington
University School of Medicine) had no effect at concentra-
tions up to 300 ng/ml (10-8 M) . Pure porcine insulin had no
effect at concentrations ashigh as 600 ng/ml . Lastly, a purified
preparation of mouse submaxillary gland EGF had no effect
at the highest concentration tested (600 ng/ml) .
Van Zant and Goldwasser (5, 6) have shown that epo causes
suppression of CSF-induced granulocyte and macrophage
colony formation by mouse bone marrow cells in vitro ;
conversely, CSF causes suppression of epo-induced erythroid
burst formation by marrow cells . The mechanisms by whichthese competitive influences are manifested on target cells is
not clear; however, the results we report here provide a
possible mechanism forour previous results.
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